Quest CEO to step down as Q3 results disappoint
This article was originally published in Clinica
Executive Summary
Quest Diagnostics' long-time CEO Surya Mohapatra has announced plans to leave the company, on the same day that its third-quarter results missed analysts' expectations. Dr Mohapatra, who is also chairman and president, will stay with Quest for up to six months while the firm searches for his successor.